KELLEY EDWARDS: Open Payments
NPI 1932656311 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 54 payments from 14 companies in 2025. Trend: 2023 $1,636 · 2024 $1,934 · 2025 $1,173
Food & beverage: $928Education: $245
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $253 |
| LEO Pharma Inc. | 10 | $159 |
| ABBVIE INC. | 13 | $156 |
| Galderma Laboratories, L.P. | 1 | $95 |
| Regeneron Healthcare Solutions, Inc. | 5 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 2 | $78 |
| Hill Dermaceuticals, Inc. | 1 | $74 |
| GENZYME CORPORATION | 2 | $68 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
Products named: TREMFYA, DUPIXENT, RINVOQ, ANZUPGO, Sotyktu, Tolak, ADBRY, SKYRIZI.
Industry payments across IN — which companies pay providers there.
